Vivos closes $7.5M private placement with Seneca; launches strategic alliance for sleep apnea treatment

Vivos Therapeutics, Inc.

Gross proceeds of $7.5M from sale of 3,220,266 shares/pre-funded warrants and 5-year warrants at $2.329/share to Seneca affiliate V-CO.
Strategic alliance with Rebis Health (Colorado) to jointly offer CPAP and Vivos' oral appliances at two centers starting July 2024; revenue-sharing model.
Seneca receives board observation rights and a management services fee of $37,500/quarter; cash participation in alliance net cash flow.
Company intends to use proceeds for working capital; must file resale registration by July 25, 2024.
Management expects new model to reduce cash burn, improve gross profit per case, and drive revenue growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.